This line chart displays closing price by date using the aggregation sum. The data is filtered where the stock is MMD. The data is about stocks per day.

The Myotonic Muscular Dystrophy (MMD) Treatments market is experiencing steady growth, projected to reach a market size of $2.5 Billion by 2025, with a Compound Annual Growth Rate (CAGR) of 5%. This growth is driven by several factors. Increasing prevalence of MMD, coupled with advancements in understanding the disease's underlying mechanisms, are fueling the development of novel therapies. The pipeline includes promising gene therapies and targeted medications aimed at addressing the core pathology of MMD, offering hope for improved patient outcomes. The market is segmented by treatment type (medications, rehabilitative therapies, devices, surgeries) and application (hospitals, specialty clinics, ambulatory surgery centers). While medications currently dominate the market share, the increasing adoption of innovative rehabilitative therapies and advanced devices is anticipated to drive substantial growth in these segments over the forecast period (2025-2033). North America and Europe currently hold the largest market share due to higher healthcare expenditure and robust research and development activities in these regions. However, emerging economies in Asia-Pacific are poised for significant expansion, driven by rising awareness and increasing healthcare infrastructure development. Regulatory approvals for new therapies and increasing patient advocacy are also key drivers for market expansion. Despite positive growth projections, the market faces certain restraints. High treatment costs associated with novel therapies, along with the complexity and length of clinical trials for new drug development, pose significant challenges. Furthermore, the relatively low prevalence of MMD compared to other neuromuscular diseases limits the overall market size. However, ongoing research efforts and collaborative initiatives between pharmaceutical companies, research institutions, and patient advocacy groups are working to overcome these barriers and accelerate the development of effective and affordable MMD treatments. The long-term outlook for the MMD treatment market remains optimistic, with continued advancements likely to significantly improve the quality of life for patients affected by this debilitating disease.

Mexico Consumer Price Index (CPI): HC: MMD: MD: Glasses, Orthopedically & Hearing Aids data was reported at 105.365 16Jul2018-31Jul2018=100 in Mar 2019. This records an increase from the previous number of 105.098 16Jul2018-31Jul2018=100 for Feb 2019. Mexico Consumer Price Index (CPI): HC: MMD: MD: Glasses, Orthopedically & Hearing Aids data is updated monthly, averaging 74.266 16Jul2018-31Jul2018=100 from Jul 2002 (Median) to Mar 2019, with 201 observations. The data reached an all-time high of 105.365 16Jul2018-31Jul2018=100 in Mar 2019 and a record low of 52.647 16Jul2018-31Jul2018=100 in Jul 2002. Mexico Consumer Price Index (CPI): HC: MMD: MD: Glasses, Orthopedically & Hearing Aids data remains active status in CEIC and is reported by National Institute of Statistics and Geography. The data is categorized under Global Database’s Mexico – Table MX.I002: Consumer Price Index: Second Half July 2018=100.

Credit report of Mmd America Ltd Inc contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

Credit report of Mmd Monitors And Displays contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

Historical ownership data of MMD by AMERIPRISE FINANCIAL INC

Credit report of Mmd Distribution contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

Mexico Consumer Price Index (CPI): HC: MMD: Meds: Dermatological data was reported at 149.565 Jun2002=100 in Dec 2010. This records an increase from the previous number of 148.184 Jun2002=100 for Nov 2010. Mexico Consumer Price Index (CPI): HC: MMD: Meds: Dermatological data is updated monthly, averaging 121.208 Jun2002=100 from Jul 2002 (Median) to Dec 2010, with 102 observations. The data reached an all-time high of 149.565 Jun2002=100 in Dec 2010 and a record low of 100.877 Jun2002=100 in Jul 2002. Mexico Consumer Price Index (CPI): HC: MMD: Meds: Dermatological data remains active status in CEIC and is reported by Bank of Mexico. The data is categorized under Global Database’s Mexico – Table MX.I005: Consumer Price Index: 2002=100.

Credit report of Mmd Worldwide Shipping 25 Lister Avenue Newark Nj 07105 Usa contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

Credit report of Mmd Comercial Dept contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

Ferroptosis is a form of regulated cell death with roles in degenerative diseases and cancer. Excessive iron-catalyzed peroxidation of membrane phospholipids, especially those containing the polyunsaturated fatty acid arachidonic acid (AA), is central in driving ferroptosis. Here, we reveal that an understudied Golgi-resident scaffold protein, MMD, promotes susceptibility to ferroptosis in ovarian and renal carcinoma cells in an ACSL4- and MBOAT7-dependent manner. Mechanistically, MMD physically interacts with both ACSL4 and MBOAT7, two enzymes that catalyze sequential steps to incorporate AA in phosphatidylinositol (PI) lipids. Thus, MMD increases the flux of AA into PI, resulting in heightened cellular levels of AA-PI and other AA-containing phospholipid species. This molecular mechanism points to a pro-ferroptotic role for MBOAT7 and AA-PI, with potential therapeutic implications, and reveals that MMD is an important regulator of cellular lipid metabolism.

Credit report of Tissera M M D contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

Mexico Consumer Price Index (CPI): HC: MMD: Meds: Healing Materials data was reported at 135.714 Jun2002=100 in Dec 2010. This records an increase from the previous number of 133.687 Jun2002=100 for Nov 2010. Mexico Consumer Price Index (CPI): HC: MMD: Meds: Healing Materials data is updated monthly, averaging 102.969 Jun2002=100 from Jan 1995 (Median) to Dec 2010, with 192 observations. The data reached an all-time high of 135.714 Jun2002=100 in Dec 2010 and a record low of 32.505 Jun2002=100 in Jan 1995. Mexico Consumer Price Index (CPI): HC: MMD: Meds: Healing Materials data remains active status in CEIC and is reported by Bank of Mexico. The data is categorized under Global Database’s Mexico – Table MX.I005: Consumer Price Index: 2002=100.

Credit report of Mmd Food Technik Gmbh contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

Mexico Consumer Price Index (CPI): Weights: HC: MMD: Medicines: Anti allergic data was reported at 0.018 % in 2017. This stayed constant from the previous number of 0.018 % for 2016. Mexico Consumer Price Index (CPI): Weights: HC: MMD: Medicines: Anti allergic data is updated yearly, averaging 0.018 % from Dec 2010 (Median) to 2017, with 8 observations. The data reached an all-time high of 0.028 % in 2012 and a record low of 0.018 % in 2017. Mexico Consumer Price Index (CPI): Weights: HC: MMD: Medicines: Anti allergic data remains active status in CEIC and is reported by National Institute of Statistics and Geography. The data is categorized under Global Database’s Mexico – Table MX.I008: Consumer Price Index: Weights: Second Half December 2010=100.

Credit report of Mmd Commerce Industrie Sarl contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.